Elsevier投稿各种状态总结

2009-10-01 MedSci原创 MedSci原创

1. Submitted to Journal当上传结束后,显示的状态是Submitted to Journal,这个状态是自然形成的无需处理。2. With editor如果在投稿的时候没有要求选择编辑,就先到主编那,主编会分派给别的编辑。这当中就会有另两个状态:3. Editor assigned 4. Editor Declined Invitation如果编辑接手处理了就会邀请审稿人了。5

1. Submitted to Journal当上传结束后,显示的状态是Submitted to Journal,这个状态是自然形成的无需处理。
2. With editor如果在投稿的时候没有要求选择编辑,就先到主编那,主编会分派给别的编辑。这当中就会有另两个状态:
3. Editor assigned
4. Editor Declined Invitation
如果编辑接手处理了就会邀请审稿人了。
5. Reviewer(s) invited
如果审稿人接受那就会是以下状态:
6. Under review
这应该是一个漫长的等待。当然前面各步骤也可能很慢的,要看编辑的处理情况。
如果被邀请审稿人不想审,就会decline,编辑会重新邀请别的审稿人。
7. required review completed 审稿结束,等编辑处理。
8. Decision in Process到了这一步就快要有结果了,编辑开始考虑是给修改还是直接拒,当然也有可能直接接受的,但可能性很小,呵呵。
9. Minor revision/Major revision这个时候可以稍微庆祝一下了,问题不大了,因为有修改就有可能。具体怎么改就不多说了,谦虚谨慎是不可少的。
10. Revision Submitted to Journal
又开始了一个循环。
11. Accepted如果不要再审,只是小修改,编辑看后会马上显示这个状态,但如果要再审也会有上面的部分状态。一步会比较快,但也有慢的。看杂志的。

还有个状态是Rejected。希望不要出现。

其他库的状态,基本是大同小异,供参考:


In the Rapid Review® system, your manuscript has a different status assigned to it at various stages in the process. Below is a list of the status descriptions used with brief explanations.
Incomplete Submission... you have begun the submission process. The submission has been assigned a temporary (TMP) manuscript number. You must complete the submission process.
Finish My Submission... by viewing and approving the MS PDF. Once this is done, the submission will be assigned a permanent manuscript number.
MS at Check-In... the manuscript is pending a quality check by the staff or editor. This involves verifying that the MS PDF contains a complete manuscript (text, tables, figures, etc.) and is suitable for review purposes.
Conversion to PDF in Process... If the manuscript was submitted digitally, the MS PDF did not pass the QC process and is not suitable for review purposes. The staff may be in the process of converting the digital files to a new MS PDF or staff may have requested that the author send new file(s). The Journal Office is waiting for the file(s) to upload for conversion purposes.
MS Being Pre-screened... if you submitted a manuscript to a journal whose review process includes pre-screening, this status indicates that the manuscript (or the abstract) is currently being pre-screened to determine its appropriateness for the journal.
MS In Review... the manuscript has been assigned to an editor and may be awaiting reviewer selections, or the awaiting reviews.
Decision Pending... the manuscript has been reviewed and the editor is in the process of making a decision.
MS in Revision (Optional)... a decision to accept the paper with optional revisions (as suggested in the reviewer or editor comments) has been made by the editor, and a letter requesting these revisions has been sent to the author. Resubmission is anticipated.
MS in Revision (Minor)... a decision to accept the paper with minor revisions (as suggested in the reviewer or editor comments) has been made by the editor, and a letter requesting these revisions has been sent to the author. Resubmission is anticipated.
MS in Revision (Major)... a decision to reconsider the paper after major revisions (as suggested in the reviewer or editor comments) has been made by the editor, and a letter requesting these revisions has been sent to the author. Resubmission is permitted.
MS Rejected... a decision to decline publication has been made by the editor, and a rejection letter has been sent to the author.
MS Accepted... a decision to accept the paper has been made by the editor, and an acceptance letter has been sent to the author.
MS Withdrawn... the manuscript has been withdrawn at the author's request. No resubmission is permitted. Any further version must be considered as a brand new submission.
MS Deactivated... the manuscript has been deactivated due to the author's non-response in resubmitting a revised version or, in some instances, to the editor's invitation to submit a solicited paper.
MS Published... the review process is complete and the manuscript is awaiting publication or it has already been published.
Invitation/Submit Invited Paper... the editor has extended to you an invitation to submit a paper on a proposed topic. You are asked to reply by using the "Reply to Invitation" button. If you and the editor are in agreement, you can submit the invited paper by using the "Submit Invited MS" button.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2007623, encodeId=c3b0200e623fd, content=<a href='/topic/show?id=0d8d66941a' target=_blank style='color:#2F92EE;'>#elsevier#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6694, encryptionId=0d8d66941a, topicName=elsevier)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Fri Jun 04 14:59:00 CST 2010, time=2010-06-04, status=1, ipAttribution=)]

相关资讯

编辑谈投稿注意事项及正确对待审稿结果(英文PPT)

How to Publish in Biomedical JournalsTips of the Trade from an Itinerant Scientist and Journal Editor Steven J. Fliesler, PhDProfessor, Depts. of Ophthalmology and Pharmacological & Physiological

MedSci李博士应邀为浙大“基因组科学”研习班做精彩讲座!

李欣梅博士演讲PPT下载: FROM IDEA TO PAPER.pdf 2009年8月26日, MedSci专家李欣梅博士应邀出席浙大“基因组科学”研习班,并作题为《From Idea To Paper》的精彩讲座,获得学员们的一致好评,反响热烈! 由浙江大学浙江加州国际纳米技术研究院举办的 “

英文SCI论文写作、投稿过程中的注意事项

【写作前准备】 1、自己的实验结果是否够发一篇SCI文章? 2、适合发表在什么杂志?是选择专业期刊?还是综合期刊? 3、为什么类型的投稿(Types of submission)?比如Articles(论著);Reviews(综述);Reports(报告);Letter to editor(来信)等。 4、该杂志的影响因子(Impact factor)是多少,每年发表多少文章?是否有过本土中国人在

《Nature》和《Science》杂志投稿要求和说明详解

谈到全球顶级杂志,不能不提CNS,即Cell, Nature, Science。在国际上,尤其是生命科学领域,一直还是推崇这三类杂志的。虽然近年来Cell影响因子一直在Nature之下,但在生命科学领域,Cell的威望仍然居第一位的。 而Nature与Science作为两本最为权威的综合性期刊,近年来,生命科学相关的内容已占到一半以上,除了还有少量物理,天文学和化学内容外,其他行业内容已很少

MedSci参加干细胞之春系列活动--干细胞技术与应用讲座

    生物谷(Bioon.com)2009年5月20日,中国上海:"干细胞之春系列活动--干细胞技术与应用讲座"在上海好望角大饭店隆重召开,本期讲座为期两天,近300位从事干细胞及再生医学研究的科研人员、医生及教师等齐聚一堂,共谱我国干细胞产业未来宏图。     此次讲座邀请到16位国内干细胞研究及应用领域的顶级专家及知名企业相关

干细胞研究趋势分析与课题申报(下载)

下载:干细胞研究趋势分析与课题申报(PDF文件,950K) MedSci应邀参加此次盛会,并发表主题演讲“干细胞研究趋势分析与课题申报”,这里提供幻灯片下载。